Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. USPH
USPH logo

USPH Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
62.335
Open
58.720
VWAP
59.94
Vol
297.11K
Mkt Cap
902.32M
Low
58.190
Amount
17.81M
EV/EBITDA(TTM)
13.56
Total Shares
15.22M
EV
1.39B
EV/OCF(TTM)
16.68
P/S(TTM)
1.13
U.S. Physical Therapy, Inc. is an operator of outpatient physical therapy clinics and provider of industrial injury prevention services. It owns and/or manages 780 outpatient physical therapy clinics in 44 states. Its reportable segments include the Physical Therapy Operations segment and the Industrial Injury Prevention Services (IIP) segment. The Physical Therapy Operations segment consists of physical therapy, speech therapy and occupational therapy clinics and home-care physical and speech therapy practices that provide pre- and post-operative care and treatment for a variety of orthopedic-related disorders, sports-related injuries, and rehabilitation of injured workers. The IIP segment includes onsite services for clients’ employees, including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers.
Show More

Events Timeline

(ET)
2026-05-06
16:30:00
Company Reports Q1 Revenue of $198.3M, Below Expectations
select
2026-05-06
16:30:00
USPH Reaffirms 2026 EBITDA Guidance of $102M to $106M
select
2026-04-15 (ET)
2026-04-15
07:40:00
U.S. Physical Therapy Closes $450M Credit Facility
select
2026-02-25 (ET)
2026-02-25
18:40:00
Company Reports Q4 Revenue of $202.73M, Beating Expectations
select
2026-02-25
18:40:00
U.S. Physical Therapy Sees 2026 Adjusted EBITDA of $102.0M-$106.0M
select
2026-02-02 (ET)
2026-02-02
16:10:00
U.S. Physical Therapy Acquires Industrial Injury Prevention Business for $15.1 Million
select
2026-02-02
07:40:00
U.S. Physical Therapy Forms 10-Year Alliance with NYU Langone Health
select

News

NASDAQ.COM
2.0
05-07NASDAQ.COM
U.S. Physical Therapy Stock Enters Oversold Territory
  • Oversold Status Analysis: U.S. Physical Therapy, Inc. (USPH) has an RSI of 20.2, significantly below the oversold threshold of 30, indicating that the recent decline in stock price may be nearing exhaustion, attracting investors looking for buying opportunities.
  • Price Volatility Impact: USPH's stock price fell to a low of $58.55 on Thursday, contrasting sharply with its recent price of $73.65, which translates to an annualized dividend yield of 2.50%, suggesting a higher yield potential for dividend investors at current levels.
  • Dividend History Consideration: While dividends are not always predictable, investors should examine USPH's dividend history to assess the likelihood of the recent dividend being sustained, providing a basis for future investment decisions.
  • Market Sentiment Shift: Given the current oversold condition, investors may reassess USPH's investment value, especially as market sentiment shifts towards bullishness, potentially leading to increased capital inflow into the stock.
moomoo
9.5
05-06moomoo
US Physical Therapy Reports Q1 Revenue of $198.3 Million, Below IBES Estimate of $201 Million
  • Physical Therapy Revenue: The physical therapy sector reported a revenue of USD 198.3 million in Q1.

  • Comparison to Estimates: This figure is slightly below the estimated revenue of USD 201 million.

seekingalpha
9.5
05-06seekingalpha
U.S. Physical Therapy Reports Disappointing Q1 Earnings
  • Disappointing Earnings: U.S. Physical Therapy (USPH) reported a Q1 GAAP EPS of -$0.12, missing expectations by $0.61, indicating significant challenges in profitability.
  • Lackluster Revenue Growth: The company generated $198.3 million in revenue for Q1, a 7.9% year-over-year increase, yet fell short of expectations by $2.64 million, reflecting unmet market demand.
  • Decline in Operating Results: Q1 non-GAAP operating results were $7.0 million, down from $7.3 million in the same period last year, with operating results per share at $0.46, highlighting pressures on cost control and efficiency improvements.
  • Slight Increase in Adjusted EBITDA: The adjusted EBITDA for Q1 was $20.2 million, a $0.7 million increase from $19.5 million in Q1 2025, but overall financial performance remains weak, potentially impacting future investor confidence.
Newsfilter
5.0
04-27Newsfilter
PACS Group Appoints New Chief Financial Officer
  • Executive Appointment: PACS Group announced the appointment of Carey P. Hendrickson as Chief Financial Officer, effective April 27, 2026, marking a significant milestone in the company's efforts to expand its national footprint and enhance clinical leadership.
  • Extensive Experience: Hendrickson brings nearly four decades of financial leadership, having served as CFO at U.S. Physical Therapy, where he managed the financial operations of 779 outpatient clinics, demonstrating his exceptional capabilities in complex healthcare environments.
  • Leadership Transition: Hendrickson succeeds PACS co-founder Mark Hancock, who will retire on June 30, 2026, while remaining as Vice Chairman of the Board, ensuring stability during this transition period for the company.
  • Strategic Vision: Hendrickson expressed admiration for PACS's commitment to post-acute care and its leadership culture, looking forward to leveraging his extensive industry experience to contribute to the company's mission.
Newsfilter
9.5
04-22Newsfilter
U.S. Physical Therapy to Report Q1 2026 Results
  • Earnings Release Schedule: U.S. Physical Therapy will report its Q1 2026 financial results on May 6, 2026, after market close, followed by a conference call on May 7, indicating the company's commitment to transparency and investor communication.
  • Conference Call Details: The conference call is scheduled for May 7, 2026, at 10:30 AM Eastern, requiring participants to dial in 15 minutes early and provide the conference ID, ensuring smooth information dissemination.
  • Company Background: Founded in 1990, U.S. Physical Therapy owns and manages 783 outpatient clinics across 44 states, highlighting its extensive influence and market share within the industry.
  • Comprehensive Service Offerings: The company provides a wide range of services, including preventative and post-operative care, treatment for neurological injuries, and rehabilitation for injured workers, showcasing its expertise and the demand in the physical therapy and industrial injury prevention sectors.
NASDAQ.COM
8.5
04-15NASDAQ.COM
U.S. Physical Therapy Secures $450 Million Credit Facility
  • Credit Facility Expansion: U.S. Physical Therapy has successfully closed a $450 million five-year credit facility, which includes a $175 million term loan and a $275 million revolver, indicating strong market confidence in its financial stability.
  • Improved Financing Terms: The credit facility was upsized from an initial $400 million, reflecting robust lender support, while extending the maturity of a previous $325 million facility due in June 2027, thereby enhancing the company's liquidity.
  • Key Underwriters Involved: The credit facility was arranged by Bank of America Securities as the Joint Lead Arranger and Sole Bookrunner, with participation from other banks like JP Morgan and Citizens Bank, showcasing the trust and support from multiple financial institutions.
  • Stock Price Fluctuation: Despite securing new credit support, USPH shares closed down 1.54% at $77.13 on the New York Stock Exchange, reflecting market uncertainty regarding the broader economic environment.
Wall Street analysts forecast USPH stock price to rise
4 Analyst Rating
Wall Street analysts forecast USPH stock price to rise
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
100.00
Averages
101.50
High
103.00
Current: 0.000
sliders
Low
100.00
Averages
101.50
High
103.00
Citizens
Constantine Davides
Outperform
to
Outperform
downgrade
$113 -> $98
AI Analysis
2026-05-08
New
Reason
Citizens
Constantine Davides
Price Target
$113 -> $98
AI Analysis
2026-05-08
New
downgrade
Outperform
to
Outperform
Reason
Citizens analyst Constantine Davides lowered the firm's price target on U.S. Physical Therapy to $98 from $113 and keeps an Outperform rating on the shares. Revenue and EBITDA both topped the firm's projections but trailed consensus, in large part due to adverse weather, the analyst tells investors in a research note. Citizens is a buyer on the weakness.
Jefferies
Buy
downgrade
$110 -> $102
2026-03-09
Reason
Jefferies
Price Target
$110 -> $102
2026-03-09
downgrade
Buy
Reason
Jefferies assumed coverage of U.S. Physical Therapy with a Buy rating and a price target of $102, down from $110. As the company pursues strategic hospital alliances and faces a more favorable pricing environment with improved Medicare rates, the firm sees organic growth acceleration and margin expansion, the analyst tells investors.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for USPH
Unlock Now

Valuation Metrics

The current forward P/E ratio for US Physical Therapy Inc (USPH.N) is 26.32, compared to its 5-year average forward P/E of 33.94. For a more detailed relative valuation and DCF analysis to assess US Physical Therapy Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
33.94
Current PE
26.32
Overvalued PE
38.82
Undervalued PE
29.07

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
19.86
Current EV/EBITDA
14.07
Overvalued EV/EBITDA
23.04
Undervalued EV/EBITDA
16.68

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
2.09
Current PS
1.01
Overvalued PS
2.57
Undervalued PS
1.61

Financials

AI Analysis
Annual
Quarterly

Whales Holding USPH

C
Copeland Capital Management, LLC
Holding
USPH
+2.80%
3M Return
V
Virtus Investment Advisers, LLC
Holding
USPH
+0.36%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is US Physical Therapy Inc (USPH) stock price today?

The current price of USPH is 59.29 USD — it has increased 0.49

What is US Physical Therapy Inc (USPH)'s business?

U.S. Physical Therapy, Inc. is an operator of outpatient physical therapy clinics and provider of industrial injury prevention services. It owns and/or manages 780 outpatient physical therapy clinics in 44 states. Its reportable segments include the Physical Therapy Operations segment and the Industrial Injury Prevention Services (IIP) segment. The Physical Therapy Operations segment consists of physical therapy, speech therapy and occupational therapy clinics and home-care physical and speech therapy practices that provide pre- and post-operative care and treatment for a variety of orthopedic-related disorders, sports-related injuries, and rehabilitation of injured workers. The IIP segment includes onsite services for clients’ employees, including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers.

What is the price predicton of USPH Stock?

Wall Street analysts forecast USPH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for USPH is101.50 USD with a low forecast of 100.00 USD and a high forecast of 103.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is US Physical Therapy Inc (USPH)'s revenue for the last quarter?

US Physical Therapy Inc revenue for the last quarter amounts to 198.29M USD, increased 7.89

What is US Physical Therapy Inc (USPH)'s earnings per share (EPS) for the last quarter?

US Physical Therapy Inc. EPS for the last quarter amounts to 0.33 USD, decreased -58.75

How many employees does US Physical Therapy Inc (USPH). have?

US Physical Therapy Inc (USPH) has 4200 emplpoyees as of May 10 2026.

What is US Physical Therapy Inc (USPH) market cap?

Today USPH has the market capitalization of 902.32M USD.